Wockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...

Wockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...

Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...

Twisha Sharma dowry death: Twisha Sharma's mysterious death has become a complex case with her mother-in-law, a retired judge, alleging dru...

The Narcotics Control Bureau has arrested Thancintuang, a key Myanmar-based drug trafficker. He is a major supplier of Methamphetamine and ...

Jihadi drug: India has achieved its first-ever seizure of Captagon, a synthetic stimulant known as the ‘Jihadi drug’, valued at Rs 182 cror...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Mohammed Salim Dola, a key associate of Dawood Ibrahim, has been brought to India from Turkiye. The Narcotics Control Bureau took him into ...

A major drug bust occurred in Manipur. Narcotics Control Bureau, Assam Rifles, and Manipur Police seized heroin valued at ₹8.5 crore. Two i...

Indian authorities have secured the return of notorious drug trafficker Mohammad Salim Dola from Turkiye. Dola, a key figure in Dawood Ibra...

The ET Most Innovative AI Product Awards 2026 brings together 11 distinct categories that reflect where artificial intelligence is deliveri...

New drugs are not reaching low and middle income countries. A study shows many medicines take years to become accessible globally. India's ...

This is the first time ever that an NDA from a new chemical entity (NCE) from an Indian pharma company has been filed and accepted by the U...

"With a rich legacy in marketing gastrointestinal therapies in India, we have been offering different breakthrough clinical options across ...

"In a step that can significantly reduce treatment cost by almost 80 per cent, the drug is being offered at Rs 32,495 for a 100 mg vial. Th...

{image_1} Concept Medical Inc CMI has been granted ‘Breakthrough Device Designation’ from the US Food and Drug Administration FDA for Magic...

The accelerated regulatory clearances cut the time lines for introductions of the two big brands which may be expected to be introduced by ...